济安尔香膏通过抑制肺炎和调节肠道微生物群来治疗支气管喘
Yanlin Li1, Zhenghua Wang1, Hui Zhu1
1Department of Pediatrics,Nantong Hospital of Traditional Chinese Medicine, Nantong Hospital Affiliated to Nanjing University of Chinese Medicine.
概括
江,就是这样一个人.
科学领域:
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 喘是一种慢性呼吸道疾病,其特点是气道炎症和高反应性.
- 目前的治疗方法虽然有效,但可能会产生副作用,需要探索替代疗法.
- 济安 (Jian'er Qiangshen,简称JEQS) 膏是一种具有潜在抗喘功能的传统药物.
研究的目的:
- 在小鼠模型中研究JEQS药膏对喘的治疗效果.
- 阐明JEQS作用的基本机制,包括其对炎症途径和肠道微生物群的影响.
主要方法:
- 在BALB/c小鼠中的卵胺 (OVA) 诱导喘模型.
- 肺组织组织病理学分析 (H&E,马森染色) 的肺组织.
- 对炎症性细胞因子 (IFN-γ,IL-4,IL-5,IL-13) 的测量.
- 超高性能液态色谱-飞行时间质谱 (UHPLC-TOF-MS) 用于组件分析.
- 网络药理学用于目标和途径预测.
- 用于肠道微生物群分析的16S rRNA测序.
主要成果:
- 与OVA组相比,JEQS治疗显著缓解了喘症状,改善了肺病理.
- 在肺组织中,JEQS显著降低了关键炎症性细胞因子 (IFN-γ,IL-4,IL-5,IL-13) 的水平.
- 网络药理学确定了28个活性成分和100个核心目标,包括AKT1,IL-6和TNF.
- 16S rRNA测序揭示了肠道微生物群组成的变化,蛋白质细菌和活性细菌的增加,以及特定益生菌属的主导地位.
结论:
- 杰克斯 (JEQS) 药膏对喘有显著的缓解作用.
- 治疗机制包括对炎症反应的多目标调节和肠道微生物群的调节.
- 杰克斯代表了喘管理的有希望的治疗剂,可能是通过其对肠道细菌和炎症通路的影响.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
182
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
182
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
156
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
156
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
155
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
155
01:20Asthma: Pathogenesis and Management
259
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
259
01:19Antiasthma Drugs: Leukotriene Modifiers
172
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
172
01:17Drugs Used in Lower Respiratory Disorders: Overview
278
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
278